Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Synthetic dosage-compensating miRNA circuits for quantitative gene therapy

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.03.13.584179Source: DataRank Database

Synthetic dosage-compensating miRNA circuits for quantitative gene therapy is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2024). On theSindex it has a DataRank of 0. It has been cited 9 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access9 citations

Download PDF

Cite:

Linked data & code

Dosage Compensated Gene Therapy · CaltechDATA

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)OA: greenTopics (25)Linked Datasets (1)DataCite Reuse (1)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

A. Mayfield,Rongrong Du ORCID,Viviana Gradinaru ORCID,Michael B. Elowitz ORCID,Michael Flynn ORCID

Live enrichment

PubMed:38559034 OpenAlex:https://openalex.org/W4392861031

National Institutes of Health

Grant: 3U24MH131054-02S1

Broadening access with an Armamentarium Vector Core Powered by Inclusive Research Experiences - SUPPLEMENT

National Institutes of Health

Grant: 5R01AI025535-02

IMMUNOTHERAPY WITH ANTI-IL2 RECEPTOR MONOCLONAL ANTIBODY

National Institutes of Health

Grant: 5R01EB030015-04

Cell targeting with synthetic sense-and-respond protease circuits

NIBIB NIH HHS

Grant: R01 EB030015

NIMH NIH HHS

Grant: U24 MH131054

greenLicense: cc-by-nc-nd

repositoryhttps://www.biorxiv.org/content/biorxiv/early/2024/03/14/2024.03.13.584179.full.pdf

GREENhttps://www.biorxiv.org/content/biorxiv/early/2024/03/14/2024.03.13.584179.full.pdf

repositoryhttps://www.biorxiv.org/content/biorxiv/early/2024/03/14/2024.03.13.584179.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2024.03.13.584179

repositoryhttps://doi.org/10.1101/2024.03.13.584179

Fields of Study

Genetics and Neurodevelopmental DisordersRNA Interference and Gene DeliveryCRISPR and Genetic EngineeringMedicineBiologyEngineering0303 health sciences03 medical and health sciences

Keywords

Rett syndromeGenetic enhancementGene duplicationGene dosageMECP2Gene expressionmicroRNAGeneBiologyEctopic expressionCopy-number variationRegulation of gene expressionNeuroscienceComputational biologyPhenotypeGeneticsGenome

Sustainable Development Goals

SDG 0: Good health and well-being

Dosage Compensated Gene Therapy

10.22002/hncr2-9pt15CaltechDATA